Gujarat Alkalies and Chemicals (GUJALKALI) Q4 25/26 earnings summary

Executive summary

• FY26 sales revenue reached Rs. 4,246 crore, up 7% YoY; EBITDA rose 15% to Rs. 522 crore, supported by higher plant utilization, production and selected product realizations.

• Standalone FY26 net profit was Rs. 20.84 crore; consolidated results recorded a net loss of Rs. 2.41 crore, narrowing from Rs. 65.12 crore in FY25.

Financial highlights

• Standalone FY26 total income was Rs. 4,474.70 crore, PBT Rs. 43.97 crore and PAT Rs. 20.84 crore, versus PAT of Rs. 15.82 crore in FY25.

• Standalone Q4 FY26 revenue from operations was Rs. 1,125.31 crore, PBT Rs. 8.32 crore and PAT Rs. 7.93 crore; Q4 FY25 PAT was Rs. 21.38 crore.

• Consolidated FY26 PBT was Rs. 20.72 crore versus a loss of Rs. 71.22 crore in FY25; PAT was a loss of Rs. 2.41 crore versus a loss of Rs. 65.12 crore.

• Consolidated Q4 FY26 PAT was Rs. 14.98 crore, compared with Rs. 8.82 crore in Q4 FY25.

• FY26 operating cash flow was Rs. 406.44 crore; investing and financing cash outflows were Rs. 227.93 crore and Rs. 150.25 crore, respectively.

Outlook and guidance

• FY27 commissioning pipeline includes HCI Synthesis, Chlorotoluene Down Stream, Caustic Soda Flaking, cell-element replacements and 138.60 MW renewable energy projects; expected to support top and bottom lines.

• 5,000 TPA high-purity Hydrogen Peroxide plant at Dahej is targeted to start up 18 months after the technology supplier kick-off; expected annual sales revenue is ~Rs. 42 crore.

• Digitization and AI implementation, including migration from SAP ECC to RISE with SAP S/4HANA, is planned over the next two years.